ImmunityBio, Inc. (IBRX)
NASDAQ · Healthcare
ImmunityBio, Inc. Cash on Hand 2013–2025
ImmunityBio, Inc. annual cash on hand history from 2014 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- ImmunityBio, Inc. cash on hand as of December 31, 2025: 88.3M, a 38.41% decrease year-over-year.
- ImmunityBio, Inc. cash on hand for 2025 were 88.3M, a 38.41% decrease from 2024.
- ImmunityBio, Inc. cash on hand for 2024 were 143.4M, a 45.97% decrease from 2023.
- ImmunityBio, Inc. cash on hand for 2023 were 265.5M, a 153.68% increase from 2022.
- ImmunityBio, Inc. cash on hand for 2022 were 104.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| ImmunityBio, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $88 |
| 2024 | $143 |
| 2023 | $265 |
| 2022 | $105 |
| 2021 | $181 |
| 2020 | $35 |
| 2019 | $76 |
| 2018 | $17 |
| 2017 | $24 |
| 2016 | $8 |
| 2015 | $176 |
| 2014 | $59 |
ImmunityBio, Inc. Cash on Hand — FAQ
ImmunityBio, Inc. (IBRX) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IBRX's cash on hand history?
The chart and table above show ImmunityBio, Inc.'s cash on hand by year and by quarter, including the growth rate.